首页|羟考酮复合瑞马唑仑监护下麻醉管理在单侧双通道脊柱内镜手术中的应用效果

羟考酮复合瑞马唑仑监护下麻醉管理在单侧双通道脊柱内镜手术中的应用效果

扫码查看
目的 探讨羟考酮复合瑞马唑仑监护下麻醉管理在单侧双通道脊柱内镜手术中的应用效果。方法 选取2022年6月至2023年5月于清华大学附属垂杨柳医院进行单侧双通道脊柱内镜手术的68例腰椎管狭窄症患者为研究对象,在组间基线特征可比的原则上,采用随机数字表法分为对照组(给予舒芬太尼复合瑞马唑仑)和观察组(给予羟考酮复合瑞马唑仑),每组34例。比较分析两组患者进入手术室后(T0)、取俯卧位后(T1)、手术开始时(T2)、椎管减压时(T3)、手术结束时(T4)的生命体征指标[平均动脉压(MAP)、心率(HR)、呼吸频率(RR)、脉搏血氧饱和度(SpO2)]及脑电双频指数(BIS)。比较分析两组的苏醒情况以及满意度评分。比较分析两组患者的术中不良反应发生情况。结果 T0、T1、T2、T3、T4时刻,两组患者的MAP、HR、BIS比较差异均无统计学意义(P>0。05)。T2、T3时刻,观察组患者的RR高于对照组,差异有统计学意义(P<0。05);T2时刻,观察组患者的SpO2高于对照组,差异有统计学意义(P<0。05)。两组患者的苏醒时间、苏醒时的改良警觉/镇静量表评分、苏醒时的视觉模拟评分法评分、手术医师满意度评分比较差异均无统计学意义(P>0。05)。观察组的患者满意度评分高于对照组,呼吸抑制发生率低于对照组,差异有统计学意义(P<0。05)。结论 羟考酮复合瑞马唑仑监护下麻醉管理可改善单侧双通道脊柱内镜手术患者的生命体征,提高患者的满意度,且可明显降低呼吸抑制的发生率。
Application of oxycodone combined with remimazolam under monitored anesthesia care in unilateral biportal endoscopy
Objective To evaluate the effect of oxycodone combined with remimazolam under monitored anesthesia care(MAC)in unilateral biportal endoscopy(UBE).Method 68 patients with lumbar spinal stenosis who underwent UBE in Chuiyangliu Hospital Affiliated to Tsinghua University from June 2022 to May 2023 were selected as the study objects.They were divided into control group(given sufentanil combined with remimazolam)and the observation group(given oxycodone combined with remimazolam)by the random number table,with 34 patients in each group.The vital signs indexes[mean arterial pressure(MAP),heart rate(HR),respiratory rate(RR),pulse oxygen saturation(SpO2)]and bispectral index(BIS)of the two groups were compared after entering the operating room(T0),after prone position(T1),at the beginning of surgery(T2),at the end of spinal canal decompression(T3),and at the end of surgery(T4).The recovery time and satisfaction scores of the two groups were compared.The incidence of intraoperative adverse reactions was compared between the two groups.Result At T0,T1,T2,T3,T4,there were no significant differences in MAP,HR and BIS between the two groups(P>0.05).At T2 and T3,RR in observation group was higher than that in control group,and the difference was statistically significant(P<0.05).At T2,SpO2 in observation group was higher than that in control group,and the difference was statistically significant(P<0.05).There were no significant differences in recovery time,MOAA/S score,VAS score and surgical satisfaction score between the two groups(P>0.05).The satisfaction score of patients in observation group was higher than that in control group,and the incidence of respiratory depression was lower than that in control group,and the differences were statistically significant(P<0.05).Conclusion Oxycodone combined with remimazolam under MAC can improve the vital signs,and improve satisfaction score of patients,and significantly reduce the incidence of respiratory depression of patients in UBE.

OxycodoneRemimazolamUnilateral biportal endoscopyMonitored anesthesia care

杨旺燕、李雷、任海强、郝文、杨彦伟

展开 >

清华大学附属垂杨柳医院麻醉科,北京 100022

羟考酮 瑞马唑仑 单侧双通道脊柱内镜手术 监护下麻醉管理

白求恩公益基金会恩泽疼痛管理医学研究项目

ezmr2022-062

2024

中国医刊
人民卫生出版社

中国医刊

CSTPCD
影响因子:1.14
ISSN:1008-1070
年,卷(期):2024.59(3)
  • 19